SANDOZ SACUBITRIL-VALSARTAN DIN 02549018
Status: Marketed
Holder: SANDOZ CANADA INCORPORATED
Health Canada record
| Active ingredient(s) | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 24 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 26 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09DX04 VALSARTAN AND SACUBITRIL |
| Original market date | 01-Oct-2025 |
| Current status date | 01-Oct-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02446928 | ENTRESTO | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 24 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 26 MG | Marketed |
| 02446936 | ENTRESTO | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 49 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 51 MG | Marketed |
| 02446944 | ENTRESTO | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 97 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 103 MG | Marketed |
| 02549026 | SANDOZ SACUBITRIL-VALSARTAN | SANDOZ CANADA INCORPORATED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 49 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 51 MG | Marketed |
| 02549034 | SANDOZ SACUBITRIL-VALSARTAN | SANDOZ CANADA INCORPORATED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 97 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 103 MG | Marketed |
| 02571072 | TEVA-SACUBITRIL / VALSARTAN | TEVA CANADA LIMITED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 24 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 26 MG | Approved |
| 02571080 | TEVA-SACUBITRIL / VALSARTAN | TEVA CANADA LIMITED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 49 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 51 MG | Approved |
| 02571099 | TEVA-SACUBITRIL / VALSARTAN | TEVA CANADA LIMITED | Tablet | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 97 MG; VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) 103 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35892 | 2025-08-25 | New Drug Submission (NDS) | Administrative: Change in product ownership. Administrative: Licensing Agreement between two manufacturers |
| 33494 | 2024-06-21 | New Drug Submission (NDS) | Administrative: Addition of product name |